I agree that this site is using cookies. You can find further informations here.
X
Phuphanich, Surasak
92  results:
Search for persons X
?
1

CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN A..:

Peereboom, David ; Lindsay, Ross ; Badruddoja, Michael...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii67-vii67 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Correction to: Gliosarcoma vs. glioblastoma: a retrospectiv..:

Dardis, Christopher ; Donner, David ; Sanai, Nader...
BMC Neurology.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
3

Gliosarcoma vs. glioblastoma: a retrospective case series u..:

Dardis, Christopher ; Donner, David ; Sanai, Nader...
BMC Neurology.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

CTIM-05. A PHASE 1/2 STUDY OF THE COMBINATION OF INDOXIMOD ..:

Lukas, Rimas ; Phuphanich, Surasak ; Rudnick, Jeremy...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi50-vi50 , 2021
Link: https://doi.org/10.1093/..
 
?
5

CTIM-11. PHASE 2 STUDY OF SL-701, A NOVEL IMMUNOTHERAPY, IN..:

Peereboom, David ; Lindsay, Ross ; Badruddoja, Michael...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi51-vi51 , 2021
Link: https://doi.org/10.1093/..
 
?
6

QOLP-04. THE KETOGENIC DIET PLUS STANDARD CARE FOR RECENTLY..:

Hu, Jethro ; Amaral, L J ; Gresham, Gillian...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi183-vi183 , 2021
Link: https://doi.org/10.1093/..
 
?
7

BIOM-17. BRAF MUTATION IS AN EARLY EVENT IN THE EVOLUTION O..:

Walsh, Kyle ; Xiu, Joanne ; López, Giselle...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii5-ii5 , 2020
Link: https://doi.org/10.1093/..
 
?
8

Primary CNS lymphoma commonly expresses immune response bio..:

Heimberger, Amy B ; Westin, Jason ; Mittal, Sandeep...
Neuro-Oncology Advances.  2 (2020)  1 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
9

A phase I trial of surgical resection with Gliadel Wafer pl..:

Rudnick, Jeremy D. ; Sarmiento, J. Manuel ; Uy, Benjamin...
Journal of Clinical Neuroscience.  74 (2020)  - p. 187-193 , 2020
Link: https://doi.org/10.1016/..
 
?
10

The current state of molecular testing in the treatment of ..:

El‐Deiry, Wafik S. ; Goldberg, Richard M. ; Lenz, Heinz‐Josef...
CA: A Cancer Journal for Clinicians.  69 (2019)  4 - p. 305-343 , 2019
Link: https://doi.org/10.3322/..
 
?
11

ATIM-47. NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURREN..:

Weller, Michael ; Reardon, David ; Brandes, Alba...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi12-vi12 , 2019
Link: https://doi.org/10.1093/..
 
?
12

PATH-55. MUTATIONS OF H3.3 AND H3.1 IN A LARGE COHORT OF GL..:

Sumrall, Ashley ; Mittal, Sandeep ; Phuphanich, Surasak...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi155-vi156 , 2019
Link: https://doi.org/10.1093/..
 
?
13

RARE-05. TUMOR PROFILING REVEALS EPITHELIAL-TO-MESENCHYMAL ..:

Dardis, Christopher ; Phuphanich, Surasak ; Sanai, Nader...
Neuro-Oncology.  20 (2018)  suppl_6 - p. vi237-vi237 , 2018
Link: https://doi.org/10.1093/..
 
?
14

ATIM-06. PHASE 2 TRIAL OF SL-701 + BEVACIZUMAB IN PATIENTS ..:

Peereboom, David ; Nabors, L Burt ; Kumthekar, Priya...
Neuro-Oncology.  20 (2018)  suppl_6 - p. vi2-vi2 , 2018
Link: https://doi.org/10.1093/..
 
?
15

RARE-22. FREQUENT HIGH TUMOR MUTATIONAL BURDEN (TMB) AND PD..:

Sumrall, Ashley ; Phuphanich, Surasak ; Spetzler, David...
Neuro-Oncology.  20 (2018)  suppl_6 - p. vi240-vi241 , 2018
Link: https://doi.org/10.1093/..
 
1-15